Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence, Am J Transplant, vol.12, issue.2, pp.388-99, 2012. ,
Recent advances in renal transplantation: antibody-mediated rejection takes center stage, vol.7, p.51, 1000. ,
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.16, issue.7, pp.2181-2187, 2016. ,
Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.17, issue.11, pp.2937-2981, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02316792
Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR), Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.19, issue.3, pp.894-906, 2019. ,
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.14, issue.1, pp.59-69, 2014. ,
,
, Posttransplant reduction in preexisting donor-specific antibody levels after belatacept-versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT
, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.7, pp.1774-82, 2018.
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell-and antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 2020. ,
Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study, Clin J Am Soc Nephrol CJASN, vol.6, issue.2, pp.430-439, 2011. ,
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function, J Am Soc Nephrol JASN, vol.16, issue.3, pp.763-73, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00149221
Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries, J Am Soc Nephrol JASN, vol.12, issue.3, pp.574-82, 2001. ,
,
, De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy, Transplant J, vol.94, issue.2, pp.172-179, 2012.
Antibody-Mediated Rejection of Solid-Organ Allografts, N Engl J Med, vol.379, issue.12, pp.1150-60, 201820. ,
,
, Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation, J Am Soc Nephrol JASN, vol.22, issue.5, pp.975-83, 2011.
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.6, issue.8, pp.1841-1848, 2006. ,
Transplant glomerulopathy, Mod Pathol Off J U S Can Acad Pathol Inc, vol.31, issue.2, pp.235-52, 2018. ,
The relationship between pathologic lesions of active and chronic antibodymediated rejection in renal allografts, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.12, pp.2849-56, 2018. ,
,
, Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.606-625, 2018.
Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy, Transplantation, vol.99, issue.1, pp.69-76, 2015. ,
Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy, Kidney Int, vol.89, issue.2, pp.450-458, 2016. ,
The Treatment of ,
URL : https://hal.archives-ouvertes.fr/hal-02190980
, Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis. Transplantation, vol.102, issue.4, pp.557-68, 2018.
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.4, pp.927-962, 2018. ,
,
, Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.591-605, 2018.
,
, Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group, Transplantation, vol.104, issue.5, pp.911-933, 2020.
Belatacept and Long-Term Outcomes in Kidney Transplantation, N Engl J Med, vol.374, issue.4, pp.333-376, 2016. ,
Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk, J Am Soc Nephrol JASN, vol.29, issue.3, pp.1049-62, 2018. ,
Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives, Kidney Int, vol.95, issue.4, pp.774-86, 2019. ,
Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years, Clin Exp Immunol, vol.104, issue.7, pp.250-61, 2019. ,
,
Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients, J Am Soc Nephrol JASN, vol.28, issue.6, pp.1912-1935, 2017. ,
Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies, Kidney Int, vol.91, issue.3, pp.729-766, 2017. ,
Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection, Transplantation, 2020. ,
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.20, issue.2, pp.573-81, 2020. ,
Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy, Clin Kidney J, vol.12, issue.4, pp.586-91, 2019. ,
Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?, Clin Kidney J, vol.11, issue.3, pp.413-434, 2018. ,
Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation, Kidney Int Rep, vol.3, issue.2, pp.281-90, 2018. ,
Kidney Fibrosis: Origins and Interventions, Transplantation, vol.101, issue.4, pp.713-739, 2017. ,
HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway, J Immunol Baltim Md, vol.180, issue.4, pp.2357-66, 1950. ,
HLA class I antibody-mediated endothelial and smooth muscle cell activation. Curr Opin Organ Transplant, vol.17, pp.446-51, 2012. ,
Molecular assessment of disease states in kidney transplant biopsy samples, Nat Rev Nephrol, vol.12, issue.9, pp.534-582, 2016. ,
Opportunistic infections after conversion to belatacept in kidney transplantation, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.35, issue.2, pp.336-381, 202001. ,